1. 球脊髄性筋萎縮症 Spinal and bulbar muscular atrophy Clinical trials / Disease details
臨床試験数 : 17 / 薬物数 : 16 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00303446 (ClinicalTrials.gov) | March 2006 | 15/3/2006 | Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) | Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients With Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) | Kennedy's Disease;Spinal and Bulbar Muscular Atrophy | Drug: Dutasteride;Drug: Placebo | National Institute of Neurological Disorders and Stroke (NINDS) | NULL | Completed | 18 Years | N/A | Male | 57 | Phase 2 | United States |